Active Filter(s):
Details:
The agreement provides SRS exclusive rights for sales, marketing, and distribution of Sidero’s patented biologic iron, BioFeTM, for the management of iron deficiency and related disorders in India and Southeast Asia.
Lead Product(s): FTH1
Therapeutic Area: Hematology Product Name: BioFe
Highest Development Status: Undisclosed Product Type: Large molecule
Partner/Sponsor/Collaborator: SRS Life Sciences Pte ltd
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Agreement October 13, 2020